After finishing at $8.63 in the prior trading day, Abeona Therapeutics Inc (NASDAQ: ABEO) closed at $6.99, down -19.00%. In other words, the price has decreased by -$1.64 from its previous closing price. On the day, 1397311 shares were traded.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
Our goal is to gain a better understanding of ABEO by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.81 and its Current Ratio is at 6.81. In the meantime, Its Debt-to-Equity ratio is 0.26 whereas as Long-Term Debt/Eq ratio is at 0.18.
On September 18, 2020, B. Riley FBR started tracking the stock assigning a Buy rating and target price of $5.
On February 10, 2020, SVB Leerink started tracking the stock assigning a Outperform rating and target price of $6.SVB Leerink initiated its Outperform rating on February 10, 2020, with a $6 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 06 ’24 when Seshadri Vishwas bought 20,000 shares for $4.39 per share. The transaction valued at 87,800 led to the insider holds 528,260 shares of the business.
Alvino Mark sold 7,084 shares of ABEO for $36,199 on Jan 17 ’24. The Director now owns 62,816 shares after completing the transaction at $5.11 per share. On Sep 27 ’23, another insider, Seshadri Vishwas, who serves as the Chief Executive Officer of the company, bought 20,000 shares for $4.07 each. As a result, the insider paid 81,400 and bolstered with 521,731 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ABEO now has a Market Capitalization of 185.53M and an Enterprise Value of 138.71M. For the stock, the TTM Price-to-Sale (P/S) ratio is 48.50 while its Price-to-Book (P/B) ratio in mrq is 7.84. Its current Enterprise Value per Revenue stands at 38.88 whereas that against EBITDA is -3.40.
Stock Price History:
Over the past 52 weeks, ABEO has reached a high of $9.01, while it has fallen to a 52-week low of $2.24. The 50-Day Moving Average of the stock is 6.20, while the 200-Day Moving Average is calculated to be 4.67.
Shares Statistics:
The stock has traded on average 326.61K shares per day over the past 3-months and 478.94k shares per day over the last 10 days, according to various share statistics. A total of 24.77M shares are outstanding, with a floating share count of 23.32M. Insiders hold about 5.85% of the company’s shares, while institutions hold 66.72% stake in the company. Shares short for ABEO as of Feb 29, 2024 were 1.64M with a Short Ratio of 5.03, compared to 778.47k on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 6.63% and a Short% of Float of 7.30%.
Earnings Estimates
Its stock is currently analyzed by 4 different market analysts. On average, analysts expect EPS of -$0.47 for the current quarter, with a high estimate of -$0.4 and a low estimate of -$0.51, while EPS last year was $1.53. The consensus estimate for the next quarter is -$0.51, with high estimates of -$0.45 and low estimates of -$0.58.
Analysts are recommending an EPS of between -$1.94 and -$2.38 for the fiscal current year, implying an average EPS of -$2.23. EPS for the following year is -$1.71, with 4 analysts recommending between -$1.55 and -$1.99.
Revenue Estimates
A total of 4 analysts have provided revenue estimates for ABEO’s current fiscal year. The highest revenue estimate was $3.5M, while the lowest revenue estimate was $3.5M, resulting in an average revenue estimate of $3.5M. In the same quarter a year ago, actual revenue was $1.41M, up 147.50% from the average estimate. Based on 4 analysts’ estimates, the company’s revenue will be $13.57M in the next fiscal year. The high estimate is $19.7M and the low estimate is $7.57M. The average revenue growth estimate for next year is up 287.70% from the average revenue estimate for this year.
